“…A multifaceted targeting of gait in PD or other important conditions could provide optimal results, it may be beneficial to utilize inflammation modulating pharmaceutical and natural therapies, targeting inflammasomes, toll-like receptors (TLRs) and adaptive immunity, and even opioid brain receptors ( Saleki et al, 2022b , Latifi et al, 2022 , Chen et al, 2019 , Rasoulinejad et al, 2020 , Karkhah et al, 2021 , Huang et al, 2018 , Ranjbar et al, 2021 , Saleki et al, 2022b , Gale and Martyn, 2003 ). Reduction of environmental stress could also serve as a reasonable adjunct prescription for such patients ( Fukui et al, 2018 , Razavinasab et al, 2022 ). These immune elements modulate hyperinflammation and significantly contribute to neurological disorders.…”